Raymond James Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Raymond James Financial's MDGL Position: Q3 2026 in Review
Raymond James Financial reduced its Madrigal Pharmaceuticals (MDGL) stake by 1.3% in Q3 2026, selling an estimated $135K and leaving 19,049 shares worth $9.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2181.
Raymond James Financial first reported a position in MDGL in Q4 2024 and has held it in 8 quarters since. The position peaked at $38.9M in Q4 2025. 440 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Raymond James Financial held 19,049 shares of Madrigal Pharmaceuticals worth $9.6M as of Q3 2026.
- Raymond James Financial sold 256 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $135K.
- Madrigal Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #2181 holding.
- Raymond James Financial first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
- Raymond James Financial's Madrigal Pharmaceuticals position peaked at $38.9M in Q4 2025.
- 440 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.